These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3141351)

  • 21. [Antibiotic susceptibility of Neisseria gonorrhoeae epidemic strains in Changsha].
    Zou MX; Xia ZD; Liang XH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):53-5. PubMed ID: 12934399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sensitivity of Neisseria gonorrhoeae to spectinomycin].
    Neubert U; Ruckdeschel G
    Hautarzt; 1981 Apr; 32(4):179-81. PubMed ID: 6453109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro antigonococcal activity of rosoxacin (WIN 35213).
    Warren CA; Shannon KP; Phillips I
    Br J Vener Dis; 1981 Feb; 57(1):33-5. PubMed ID: 6781706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining the in vitro susceptibility of Neisseria gonorrhoeae isolates from 8 cities in Guangdong Province through an improved microdilution method.
    Wu X; Qin X; Huang J; Wang F; Li M; Wu Z; Liu X; Pei J; Wu S; Chen H; Guo C; Xue Y; Tang S; Fang M; Lan Y; Ou J; Xie Z; Yu Y; Yang J; Chen W; Zhao Y; Zheng H
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):325-331. PubMed ID: 30292397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin.
    Aydin D; Küçükbasmaci O; Gonullu N; Aktaş Z
    Chemotherapy; 2005 May; 51(2-3):89-92. PubMed ID: 15886468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparative in-vitro activity of ofloxacin.
    Grüneberg RN; Felmingham D; O'Hare MD; Robbins MJ; Perry K; Wall RA; Ridgway GL
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in 19 clinical isolates of Neisseria gonorrhoeae in Tokyo in 2002.
    Abe H; Nishimura T; Norose Y; Aoto T; Ohzuka H; Ohkuni H
    J Infect Chemother; 2003 Dec; 9(4):310-3. PubMed ID: 14691651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
    Thakur SD; Levett PN; Horsman GB; Dillon JA
    Sex Transm Infect; 2014 Jun; 90(4):297-302. PubMed ID: 24503900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between in vitro quinolone susceptibility of Neisseria gonorrhoeae and outcome of treatment of gonococcal urethritis with single-dose ofloxacin.
    Kam KM; Lo KK; Chong LY; Au WF; Wong PY; Cheung MM
    Clin Infect Dis; 1999 May; 28(5):1165-6. PubMed ID: 10452657
    [No Abstract]   [Full Text] [Related]  

  • 31. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
    Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activity of rosoxacin, fosfomycin, cefotiam, and spectinomycin on beta-lactamase producing Neisseria gonorrhoeae.
    Dickgiesser N; Kuntz P
    Br J Vener Dis; 1984 Jun; 60(3):154-6. PubMed ID: 6329404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
    Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
    J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
    Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
    Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationic peptide of the male reproductive tract, HE2alpha, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis.
    Liao M; Ruddock PS; Rizvi AS; Hall SH; French FS; Dillon JR
    J Antimicrob Chemother; 2005 Nov; 56(5):957-61. PubMed ID: 16195256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of fluorinated quinolone antibacterials with Neisseria gonorrhoeae isolates.
    Rohlfing SR; Landmesser JE; Gerster JF; Pecore SE; Stern RM
    J Antimicrob Chemother; 1985 May; 15(5):539-44. PubMed ID: 3924878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.
    Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y
    Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auxotypes, serovars, and trends of antimicrobial resistance of Neisseria gonorrhoeae in Kigali, Rwanda (1985-93).
    Bogaerts J; Van Dyck E; Mukantabana B; Munyabikali JP; Martinez Tello W
    Sex Transm Infect; 1998 Jun; 74(3):205-9. PubMed ID: 9849557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of rosoxacin (Win 35 213) against Neisseria gonorrhoeae (author's transl)].
    Braveny I; Machka K
    Arzneimittelforschung; 1980; 30(9):1476-8. PubMed ID: 6779824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.